the Comparison Efficacy of Azithromycin With Doxycycline in the Treatment of Acne Vulgaris

Status

UNKNOWN

Phases

Phase 2

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00419848

Enrollment

100

Registered

2007-01-09

Start date

2006-08-31

Completion date

2008-02-29

Last updated

2008-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acne

Keywords

Acne, Azithromycin, Doxycycline

Brief summary

a comparison of efficacy and adverse side effects occurrence of Doxycycline and Azithromycin in the management of moderate acne vulgaris

Interventions

DRUGDoxycycline

Cap 100mg- 100mg/daily

DRUGAzithromycin

Azithromycin: Cap 250 mg- 500 mg single dose/daily - 3 times per week

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 30 Years

Healthy volunteers

Yes

Inclusion criteria

* Between 18 to 30 year old * Moderate facial Acne(At least 10 inflammatory lesions with maximum 3 nodules and pseudocysts

Exclusion criteria

* Pregnancy * Breast Feeding * Acne Fulminant * Acne conglobate * Isotretinoin therapy within past 6 months * topical treatment in last 2 weeks * use of systemic antibiotic in the last month * Hyperandrogenism symptoms * Menstrual irregularity

Design outcomes

Primary

Measure	Time frame
change in acne lesions	12 weeks

Secondary

Measure	Time frame
global response rates, patient's own assessment, side effects and compliance	12 weeks

Countries

Iran

Contacts

Primary ContactParviz Toossi, M.D.

src@sbmu.ac.ir98-21-22744393

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026